Literature DB >> 15090463

Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice.

Dengshun Miao1, Jiarong Li, Yingben Xue, Hanyi Su, Andrew C Karaplis, David Goltzman.   

Abstract

We investigated the relative contributions of PTH and PTHrP to the skeletal phenotype of mice deficient in PTH (PTH(-/-)). PTH(-/-) mice and PTH(-/-) mice lacking one allele encoding PTHrP (PTH(-/-)PTHrP(+/-)) were compared. Both mutants displayed similar biochemical abnormalities of hypoparathyroidism, but skeletal PTHrP mRNA and protein were decreased in PTH(-/-)PTHrP(+/ -) mice. PTH(-/-) mice had increased trabecular bone volume with diminished bone turnover. PTHrP haploinsufficiency reduced trabecular bone of the PTH(-/-) mice to levels below those in wild-type animals by decreasing osteoprogenitor cell recruitment, enhancing osteoblast apoptosis, and diminishing bone formation. The results show that the increased trabecular bone volume in PTH-deficient mice is due to diminished PTH-induced osteoclastic bone resorption and persistent PTHrP-stimulated osteoblastic bone formation. They also illustrate the changing role of PTHrP during bone development, demonstrate its bone- forming function in the postnatal state, and support its pharmacological potential as an anabolic agent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15090463     DOI: 10.1210/en.2003-1695

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  40 in total

1.  PTHrP 1-141 and 1-86 increase in vitro bone formation.

Authors:  Blake Eason Hildreth; Jillian L Werbeck; Nandu K Thudi; Xiyun Deng; Thomas J Rosol; Ramiro E Toribio
Journal:  J Surg Res       Date:  2010-03-16       Impact factor: 2.192

2.  Comparison of active vitamin D compounds and a calcimimetic in mineral homeostasis.

Authors:  Loan Nguyen-Yamamoto; Isabel Bolivar; Stephen A Strugnell; David Goltzman
Journal:  J Am Soc Nephrol       Date:  2010-07-22       Impact factor: 10.121

3.  Safety and tolerability of subcutaneous PTHrP(1-36) in healthy human volunteers: a dose escalation study.

Authors:  Mara J Horwitz; Mary Beth Tedesco; Susan M Sereika; Adolfo Garcia-Ocaña; Alessandro Bisello; Bruce W Hollis; Caren Gundberg; Andrew F Stewart
Journal:  Osteoporos Int       Date:  2005-09-07       Impact factor: 4.507

Review 4.  The role of biomineralization in disorders of skeletal development and tooth formation.

Authors:  Christopher S Kovacs; Catherine Chaussain; Philip Osdoby; Maria Luisa Brandi; Bart Clarke; Rajesh V Thakker
Journal:  Nat Rev Endocrinol       Date:  2021-05-04       Impact factor: 43.330

5.  Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer.

Authors:  Qiang Fu; Stavros C Manolagas; Charles A O'Brien
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

6.  Osteoblast-derived PTHrP is a physiological regulator of bone formation.

Authors:  T John Martin
Journal:  J Clin Invest       Date:  2005-09       Impact factor: 14.808

7.  Parathyroid hormone-related protein regulates osteoclast inhibitory lectin expression via multiple signaling pathways in osteoblast-like cells.

Authors:  Fang Zheng; Hui Liang; Rui Liu; Jin-Xing Quan; Xiao-Xia Li; Chen-Lin Dai; Gang Guo; Jing-Yu Zhang; Bao-Li Wang
Journal:  Endocrine       Date:  2008-11-06       Impact factor: 3.633

8.  Activation of the acquired immune response reduces coupled bone formation in response to a periodontal pathogen.

Authors:  Yugal Behl; Michelle Siqueira; Javier Ortiz; Jingchao Li; Tesfahun Desta; Dan Faibish; Dana T Graves
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

9.  The N- and C-terminal domains of parathyroid hormone-related protein affect differently the osteogenic and adipogenic potential of human mesenchymal stem cells.

Authors:  Antonio Casado-Diaz; Raquel Santiago-Mora; José Manuel Quesada
Journal:  Exp Mol Med       Date:  2010-02-28       Impact factor: 8.718

Review 10.  Control of RANKL gene expression.

Authors:  Charles A O'Brien
Journal:  Bone       Date:  2009-08-27       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.